Randomized, open-label clinical trial (Phase 1) to evaluate safety, tolerability, pharmacokinetics and food effects of a single dose of IM-250 in healthy volunteers

Status

Completed

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2024-518155-37-00

Acronym

IM-103

Enrollment

Registered

2025-02-10

Start date

2025-02-14

Completion date

2025-04-16

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy volunteers

None listed

Sex/Gender

All

Age

18 Years to 64 Years

Bulgaria

None listed

Source: EU CTIS · Data processed: Feb 4, 2026